Vesicular stomatitis virus-infected L1210 murine leukemia cells: increased immunogenicity and altered surface antigens
- PMID: 189042
- DOI: 10.1093/jnci/58.1.83
Vesicular stomatitis virus-infected L1210 murine leukemia cells: increased immunogenicity and altered surface antigens
Abstract
Homogenates of L1210 cells infected in vitro with vesicular stomatitis virus (VSV) were immunogenic agains a tumor graft of 100 times the LD50 dose of L1210 cells" whereas those of uninfected cells were not. The immunogenicity of intact X-irradiated L1210 cells was distinguishable from that of VSV-infected cell homogenates on the basis of the susceptibility of immunogenicity to experimental procedures used in preparation of the immunogenic homogenates: Homogenization of intact X-irradiated cells or their infection with VSV prior to irradiation led to loss of immunogenicity. In addition, uninfected cell homogenates were not made immunogenic nor was the immunogenicity of VSV-infected cell homogenates eliminated by X-irradiation. At the time of tumor challenge, sera from mice that were effectively immunized with VSV-infected cell homogenate showed a high VSV-neutralizing titer but no complement-dependent cytotoxicity for L1210 cells. Quantitative absorption studies demonstrated that VSV infection led to a marked reduction in L1210 surface antigens recognized by cytotoxic alloantibody; spatial association between these antigens and VSV antigens was not demonstrable on VSV-infected cells. Antigens recognized by heterologous antiserum to L1210 cells were also reduced following VSV infection.
Similar articles
-
Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.Gan. 1979 Dec;70(6):769-76. Gan. 1979. PMID: 94022
-
Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.Cancer Res. 1975 Apr;35(4):946-52. Cancer Res. 1975. PMID: 1090366
-
Interactions of vesicular stomatitis virus with murine cell surface antigens.J Virol. 1976 Sep;19(3):833-45. doi: 10.1128/JVI.19.3.833-845.1976. J Virol. 1976. PMID: 61285 Free PMC article.
-
Antigenic tumor cell variants obtained with mutagens.Adv Cancer Res. 1983;39:121-51. doi: 10.1016/s0065-230x(08)61034-9. Adv Cancer Res. 1983. PMID: 6353885 Review. No abstract available.
-
Solubilization of biologically active cell surface antigens.Contemp Top Mol Immunol. 1976;5:87-124. doi: 10.1007/978-1-4684-8142-6_4. Contemp Top Mol Immunol. 1976. PMID: 137098 Review. No abstract available.
Cited by
-
Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.Biomedicines. 2017 Jan 4;5(1):3. doi: 10.3390/biomedicines5010003. Biomedicines. 2017. PMID: 28536346 Free PMC article. Review.
-
Enhanced tumor susceptibility of immunocompetent mice infected with lymphocytic choriomeningitis virus.Cancer Immunol Immunother. 1990;32(2):117-24. doi: 10.1007/BF01754208. Cancer Immunol Immunother. 1990. PMID: 2289203 Free PMC article.
-
Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia.Cancer Immunol Immunother. 1988;26(2):132-8. doi: 10.1007/BF00205606. Cancer Immunol Immunother. 1988. PMID: 3359458 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources